Skip to main content

Researchers have announced the first successful step towards the prevention of cancer relapse in high-risk leukemia patients.

Researchers have announced the first successful step towards the prevention of cancer relapse in high-risk leukemia patients. The first patient in their research project, which involves deploying natural killer cells, has demonstrated a clear, satisfactory response, said Asst. Professor Dr. Udomsak Bunworasate from Chulalongkorn University’s Faculty of Medicine. 
Dr. Koramit Suppipat, who heads the research on cell therapy for cancer patients at the faculty, explained that natural killer cells are present in human bodies and are crucial to the immune system. He said his institute had in 2014, initiated the project to research and develop a way to treat leukemia among high-risk groups with natural killer cells, thanks to funding from the Thailand Centre of Excellence for Life Science (TCELS). Last year, with more funds from other units, his team could start the pilot research project to conduct clinical trials using natural killer cells from donors on a high-risk group of acute myeloid leukemia patients.

 

Share this article

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday

thailandtoday thailandtoday thailandtoday